These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 169808)
21. Revertants of mouse cells transformed by murine sarcoma virus: flat variants without a rescuable sarcoma virus from a clone of BALB/3T3 transformed by Kirsten MSV. Nomura S; Dunn KJ; Mattern CF; Hartley JW; Fischinger PJ J Gen Virol; 1974 Nov; 25(2):207-18. PubMed ID: 4140213 [No Abstract] [Full Text] [Related]
22. Cycloheximide-dependent reversion of human cells transformed by MSV and chemical carcinogen. Cho HY; Rhim JS Science; 1979 Aug; 205(4407):691-3. PubMed ID: 223242 [TBL] [Abstract][Full Text] [Related]
23. Rescue of a rat tropic rat hepatoma virus pseudotype Kirsten sarcoma virus by co-cultivation of hepatoma tissue culture cells with K-NRK cells. Yang SS; Chan C; Thompson EB J Gen Virol; 1976 May; 31(2):239-43. PubMed ID: 180242 [TBL] [Abstract][Full Text] [Related]
24. Chemical induction of focus-forming virus from nonproducer cells transformed by murine sarcoma virus. Aaronson SA Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3069-72. PubMed ID: 4332005 [TBL] [Abstract][Full Text] [Related]
25. Tumor inhibiting capacity of spleen and lymph node cells from mice with murine sarcoma virus (MSV-M)-induced tumors. Weiland E; Mussgay M Z Immunitatsforsch Exp Klin Immunol; 1975 Nov; 150(5):414-23. PubMed ID: 181922 [TBL] [Abstract][Full Text] [Related]
26. Mutants of nonproducer cell lines transformed by murine sarcoma viruses. I. Induction, isolation, particle production, and tumorigenicity. Hatanaka M; Klein R; Toni R; Walker J; Gilden R J Exp Med; 1973 Aug; 138(2):356-63. PubMed ID: 4352583 [TBL] [Abstract][Full Text] [Related]
27. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone. Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766 [TBL] [Abstract][Full Text] [Related]
28. Induction of a novel transforming virus (MSV-Z) from sarcoma-positive leukemia-negative 3T3FL mouse cells. Nomura S; Fischinger PJ Virology; 1976 Feb; 69(2):635-46. PubMed ID: 56806 [No Abstract] [Full Text] [Related]
29. Inhibition of murine sarcoma virus induced transformation in an adenovirus -- NRK system. Bourne KA; Major EO; Khoobyarian N In Vitro; 1979 Sep; 15(9):664-8. PubMed ID: 231569 [TBL] [Abstract][Full Text] [Related]
30. Ribonucleic acid components of murine sarcoma and leukemia viruses. Maisel J; Klement V; Lai MM; Ostertag W; Duesberg P Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3536-40. PubMed ID: 4357879 [TBL] [Abstract][Full Text] [Related]
31. Induction of rat brain tumor with xenotropic pseudotype murine sarcoma virus. Okazaki T Acta Med Okayama; 1983 Jun; 37(3):193-206. PubMed ID: 6308962 [TBL] [Abstract][Full Text] [Related]
32. Exclusive involvement of H-2Db or H-2Kd product in the interaction between T-killer lymphocytes and syngeneic H-2b or H-2d viral lymphomas. Gomard E; Duprez V; Reme T; Colombani MJ; Levy JP J Exp Med; 1977 Oct; 146(4):909-22. PubMed ID: 197198 [TBL] [Abstract][Full Text] [Related]
33. Transformation of Indian muntjac cells by murine and avian sarcoma viruses. Yuasa Y; Hirai R; Huh N; Shimojo H; Yamamoto T Gan; 1978 Jun; 69(3):441-5. PubMed ID: 208907 [TBL] [Abstract][Full Text] [Related]
34. In vivo interactions between murine leukemia and sarcoma viruses. Chieco-Bianchi L; Collavo D; Colombatti A; Biasi G Bibl Haematol; 1975; (40):613-20. PubMed ID: 169829 [TBL] [Abstract][Full Text] [Related]
35. Sarcoma-virus-related RNA sequences in normal rat cells. Tsuchida N; Gilden RV; Hatanaka M Proc Natl Acad Sci U S A; 1974 Nov; 71(11):4503-7. PubMed ID: 4140505 [TBL] [Abstract][Full Text] [Related]